North America Cardiac Rhythm Management Devices Market Outlook to 2025

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$5995
Buy Report

Published: May 15, 2018 Report Code: GDMECR0794DB-ST

Select Item

“What is covered in the report about the “North America Cardiac Rhythm Management Devices Market”?
GlobalData’s “North America Cardiac Rhythm Management Devices Market Outlook to 2025” report is a comprehensive databook report, covering key market data on the North America Cardiac Rhythm Management Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD), Implantable Loop Recorders (ILR) and Pacemakers.

The North America Cardiac Rhythm Management Devices Market report provides key information and data on
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2015 to 2025.
• 2017 company share and distribution share data for Cardiac Rhythm Management Devices market.
• Global corporate-level profiles of key companies operating within the North America Cardiac Rhythm Management Devices Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

North America Cardiac Rhythm Management Devices is segmented as follows:
• Cardiac Resynchronisation Therapy (CRT)
• Implantable Cardioverter Defibrillators (ICD)
• Implantable Loop Recorders (ILR)
• Pacemakers
Key Reasons to Purchase
The North America Cardiac Rhythm Management Devices Market report helps you to develop
• Business strategies by identifying the key market segments poised for strong growth in the future.
• Market-entry and market expansion strategies.
• Design competition strategies by identifying who-stands-where in the market.
• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
• Understand the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Key companies covered in the “North America Cardiac Rhythm Management Devices Market Outlook to 2025” report
• Abbott Laboratories
• Boston Scientific Corp
• Medtronic plc

The GlobalData Differentiation
Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.
The data and analysis within this report are driven by GlobalData Medical Equipment (GDME) databases. GlobalData Medical Equipment database gives you the key information required to drive sales, investment and deal-making activity in your business. It includes the following:
• 15,000+ data tables showing market size across more than 780 medical equipment segments and 39 countries, from 2015 and forecast to 2025
• 15,000+ primary interviews, conducted annually to ensure data and report quality
• 2,000+ industry-leading analysis and procedure reports covering growing sectors, market trends, investment opportunities and competitive landscape
• 61,791+ medical equipment company profiles
• 4,300+ company profiles of medical equipment manufacturers in China and India
• 825+ companies’ revenue splits and market shares
• 1,900+ quarterly and annual medical equipment company financials
• 940+ medical equipment company SWOTs
• 24,300+ pipeline product profiles
• 43,200+ marketed product profiles
• 39,200+ clinical trials
• 44,900+ trial investigators
• 6,700+ reports on companies with products in development
• 38,300+ deals in the medical equipment industry
• 1,300+ surgical and diagnostic procedures by therapy area
• 50+ key healthcare indicators by country

For more information or to receive a free demonstration of the service, please visit:
http://globaldata.com/medical/Home.aspx

Custom Requirements
Contact us to discuss the areas of your business where you need external input, and we will work with you to identify the strongest way forward to meet your needs.

Scope

NA

Table of Contents

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 6

1.2 List of Figures 7

2 Introduction 9

2.1 What Is This Report About? 9

2.2 Cardiac Rhythm Management Devices Segmentation 9

2.3 Definitions of Markets Covered in the Report 10

3 Cardiac Rhythm Management Devices Market, North America 12

3.1 Cardiac Rhythm Management Devices Market, North America, Revenue ($m), 2015-2025 12

3.2 Cardiac Rhythm Management Devices Market, North America, Revenue ($m), 2015-2025 14

3.3 Cardiac Rhythm Management Devices Market, North America, Volume (Units), 2015-2025 17

3.4 Cardiac Rhythm Management Devices Market, North America, Volume (Units), 2015-2025 19

3.5 Cardiac Rhythm Management Devices Market, North America, Company Share by Revenue ($m), 2017 22

4 Cardiac Rhythm Management Devices Market, Canada 24

4.1 Cardiac Rhythm Management Devices Market, Canada, Revenue ($m), 2015-2025 24

4.1.1 Cardiac Resynchronisation Therapy (CRT) Market, Canada, Revenue ($m), by Segment, 2015-2025 27

4.1.2 Implantable Cardioverter Defibrillators (ICD) Market, Canada, Revenue ($m), by Segment, 2015-2025 30

4.1.3 Pacemakers Market, Canada, Revenue ($m), by Segment, 2015-2025 33

4.2 Cardiac Rhythm Management Devices Market, Canada, Volume (Units), 2015-2025 36

4.2.1 Cardiac Resynchronisation Therapy (CRT) Market, Canada, Volume (Units), by Segment, 2015-2025 39

4.2.2 Implantable Cardioverter Defibrillators (ICD) Market, Canada, Volume (Units), by Segment, 2015-2025 42

4.2.3 Pacemakers Market, Canada, Volume (Units), by Segment, 2015-2025 45

4.3 Cardiac Rhythm Management Devices Market, Canada, Average Price ($), 2015-2025 48

4.4 Cardiac Rhythm Management Devices Market, Canada, Distribution Share by Revenue ($m), 2017 50

4.5 Cardiac Rhythm Management Devices Market, Canada, Company Share by Revenue ($m), 2017 51

5 Cardiac Rhythm Management Devices Market, Mexico 53

5.1 Cardiac Rhythm Management Devices Market, Mexico, Revenue ($m), 2015-2025 53

5.1.1 Cardiac Resynchronisation Therapy (CRT) Market, Mexico, Revenue ($m), by Segment, 2015-2025 56

5.1.2 Implantable Cardioverter Defibrillators (ICD) Market, Mexico, Revenue ($m), by Segment, 2015-2025 58

5.1.3 Pacemakers Market, Mexico, Revenue ($m), by Segment, 2015-2025 60

5.2 Cardiac Rhythm Management Devices Market, Mexico, Volume (Units), 2015-2025 62

5.2.1 Cardiac Resynchronisation Therapy (CRT) Market, Mexico, Volume (Units), by Segment, 2015-2025 65

5.2.2 Implantable Cardioverter Defibrillators (ICD) Market, Mexico, Volume (Units), by Segment, 2015-2025 67

5.2.3 Pacemakers Market, Mexico, Volume (Units), by Segment, 2015-2025 69

5.3 Cardiac Rhythm Management Devices Market, Mexico, Average Price ($), 2015-2025 71

5.4 Cardiac Rhythm Management Devices Market, Mexico, Distribution Share by Revenue ($m), 2017 73

5.5 Cardiac Rhythm Management Devices Market, Mexico, Company Share by Revenue ($m), 2017 74

6 Cardiac Rhythm Management Devices Market, United States 76

6.1 Cardiac Rhythm Management Devices Market, United States, Revenue ($m), 2015-2025 76

6.1.1 Cardiac Resynchronisation Therapy (CRT) Market, United States, Revenue ($m), by Segment, 2015-2025 79

6.1.2 Implantable Cardioverter Defibrillators (ICD) Market, United States, Revenue ($m), by Segment, 2015-2025 81

6.1.3 Pacemakers Market, United States, Revenue ($m), by Segment, 2015-2025 83

6.2 Cardiac Rhythm Management Devices Market, United States, Volume (Units), 2015-2025 85

6.2.1 Cardiac Resynchronisation Therapy (CRT) Market, United States, Volume (Units), by Segment, 2015-2025 88

6.2.2 Implantable Cardioverter Defibrillators (ICD) Market, United States, Volume (Units), by Segment, 2015-2025 90

6.2.3 Pacemakers Market, United States, Volume (Units), by Segment, 2015-2025 92

6.3 Cardiac Rhythm Management Devices Market, United States, Average Price ($) , 2015-2025 94

6.4 Cardiac Rhythm Management Devices Market, United States, Distribution Share by Revenue ($m), 2017 96

6.5 Cardiac Rhythm Management Devices Market, United States, Company Share by Revenue ($m), 2017 97

7 Overview of Key Companies in North America Cardiac Rhythm Management Devices Market 99

7.1 Medtronic Plc 99

7.1.1 Company Overview 99

7.2 Abbott Laboratories 99

7.2.1 Company Overview 99

7.3 Biotronik AG 99

7.3.1 Company Overview 99

7.4 Boston Scientific Corp 99

7.4.1 Company Overview 99

8 Cardiac Rhythm Management Devices Market Pipeline Products 100

9 Recent Developments 102

9.1 Corporate Communications 102

9.1.1 Apr 15, 2018: Genentech to Present Phase Ib/II Study Results of RG6206 102

9.1.2 Apr 10, 2018: iRhythm Technologies Appoints UCLA and Cedars-Sinai Professor C. Noel Bairey Merz, M.D. to its Board of Directors 102

9.1.3 Mar 13, 2018: Orthofix Announces Appointment of John Sicard to Board of Directors 103

9.1.4 Feb 13, 2018: Proteus Digital Health Appoints Joseph Swedish As Board Director 103

9.1.5 Jan 10, 2018: Ventripoint Appoints Head of Sales for North America 103

9.1.6 Dec 19, 2017: Ventripoint Diagnostics Provides Corporate Update 104

9.1.7 Nov 20, 2017: Follicum applies for the start of a Phase II study at the German Medicines Agency 104

9.1.8 Oct 11, 2017: New Data Shows That for Some Patients, Deep Brain Stimulation May Address Chronic Depression 105

9.1.9 Oct 04, 2017: Boston Scientific Appoints Desiree Ralls-Morrison General Counsel and Corporate Secretary 106

9.1.10 Sep 05, 2017: Former U. S. Surgeon General Dr. Regina Benjamin Joins the Board of Proteus Digital Health 107

9.1.11 Aug 23, 2017: Senior Novartis Executive Joins Proteus Digital Health as Chief Financial Officer 107

9.1.12 Jul 20, 2017: A Third Highly Successful Ultrasound Executive joins Ventripoint 108

9.1.13 Jun 21, 2017: Highly Successful Global Industry Sales & Marketing Executives Hired by Ventripoint 108

9.1.14 Jun 14, 2017: Spectranetics Announces Election of New Chairperson of the Board of Directors 109

9.2 Financial Announcements 109

9.2.1 Apr 25, 2018: Boston Scientific Announces Results For First Quarter 2018 109

9.2.2 Apr 16, 2018: USRM Reports 2017 Financial Results 111

9.2.3 Mar 28, 2018: MicroPort Scientific Announces 2017 Annual Results 112

9.2.4 Mar 06, 2018: Stereotaxis Reports 2017 Fourth Quarter And Full Year Financial Results 113

9.2.5 Feb 26, 2018: Orthofix International Reports Fourth Quarter And Fiscal 2017 Financial Results 115

9.2.6 Feb 08, 2018: Surmodics Reports First Quarter Fiscal 2018 Results, Updates Fiscal 2018 Guidance 116

9.2.7 Feb 01, 2018: Boston Scientific Announces Results for Fourth Quarter and Full Year 2017 116

9.2.8 Jan 23, 2018: Glytec's Software Yields Superior Patient Outcomes According to Four New Studies in Journal of Diabetes Science and Technology 118

9.2.9 Jan 09, 2018: Boston Scientific Announces Preliminary Unaudited Sales For The Fourth Quarter And Full Year Ended December 31, 2017 119

9.2.10 Jan 09, 2018: Orthofix Announces Preliminary 2017 Fourth Quarter and Full Year Net Sales Results 120

9.2.11 Jan 08, 2018: Stereotaxis Reports Preliminary Fourth Quarter 2017 Revenue Results 121

9.2.12 Dec 12, 2017: Cyclacel Announces Presentation of Results From Phase 3 Seamless Study at Ash Annual Meeting 121

9.2.13 Nov 09, 2017: Stereotaxis Reports Third Quarter 2017 Financial Results 122

9.2.14 Nov 08, 2017: Surmodics Reports Fourth Quarter Fiscal 2017 Results and Provides Fiscal 2018 Guidance 123

9.2.15 Nov 01, 2017: iRhythm Technologies Announces Third Quarter 2017 Financial Results And Raises Guidance For Full Year 2017 124

9.2.16 Oct 30, 2017: Orthofix International Reports Third Quarter 2017 Financial Results 125

9.2.17 Oct 26, 2017: Boston Scientific Announces Results For Third Quarter 2017 125

9.2.18 Oct 25, 2017: Bard Announces Third Quarter Results 126

9.2.19 Sep 26, 2017: Psychemedics Announces Addition of FDA-Cleared Benzodiazepines Hair Test 128

9.2.20 Sep 26, 2017: DFB Soria Gives Update on Enrollment in Phase 2 Clinical Trial of SOR007 (Nanoparticle Paclitaxel) Ointment for Actinic Keratosis (AK) 130

9.2.21 Aug 29, 2017: Medovex Receives Regulatory Approval from Australia's Therapeutic Goods Administration for its DenerveX System 131

9.2.22 Aug 15, 2017: CareRay Exhibits At FIME 2017 133

9.2.23 Aug 10, 2017: Stereotaxis Reports Second Quarter 2017 Financial Results 134

9.2.24 Aug 09, 2017: U.S. Stem Cell Reports Most Successful Financial Performance in the Company's History 134

9.2.25 Aug 07, 2017: Orthofix International Reports Second Quarter 2017 Financial Results 135

9.2.26 Aug 03, 2017: Surmodics Reports Third Quarter Fiscal 2017 Results and Updates Fiscal 2017 Guidance 136

9.2.27 Aug 03, 2017: Spectranetics Reports Second Quarter 2017 Revenue of $74.7 million 136

9.2.28 Aug 02, 2017: iRhythm Technologies Announces Second Quarter 2017 Financial Results 136

9.2.29 Jul 27, 2017: Boston Scientific Announces Results for Second Quarter 2017 137

9.2.30 Jun 21, 2017: Tolero Pharmaceuticals to Expand Enrollment of Phase II Study of Alvocidib in MCL-1-Dependent AML into Europe 139

9.2.31 May 08, 2017: Stereotaxis Reports 2017 First Quarter Financial Results 139

9.2.32 Apr 27, 2017: Boston Scientific Announces Results For First Quarter 2017 140

9.2.33 Apr 27, 2017: Surmodics Reports Second Quarter Fiscal 2017 Results, Updates Fiscal 2017 Financial Guidance 141

9.2.34 Apr 27, 2017: Spectranetics Reports First Quarter 2017 Revenue of $69.7 million 142

9.3 Legal And Regulatory 142

9.3.1 Aug 28, 2017: FDA warns US Stem Cell Clinic of significant deviations 142

9.3.2 Aug 03, 2017: Zoll Announces Jury Verdict in Zoll/Philips Patent Dispute 143

9.3.3 May 31, 2017: AngioDynamics Lawsuit Alleges C.R. Bard is Violating Antitrust Laws, Harming Competition and Limiting Access 143

9.4 Other Significant Developments 144

9.4.1 Feb 06, 2018: USRM Seeing Explosive Increase in Demand for Stem Cell Therapy 144

9.4.2 Aug 28, 2017: U.S. Stem Cell Clinic Acknowledges Warning Letter By The FDA and Responds 144

9.4.3 Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day 145

9.4.4 Jun 01, 2017: Nexus Pharmaceuticals Receives FDA Approval for Sodium Nitroprusside Injection 146

9.5 Product News 147

9.5.1 Nov 27, 2017: Ventripoint Invents a New Way to Track Ultrasound Probes That Will Speed up Exams 147

9.6 Strategy And Business Planning 147

9.6.1 Feb 07, 2018: Caisson Interventional Expanding in Maple Grove 147

9.6.2 Dec 11, 2017: Anthera Pharmaceuticals Announces Positive Outcome of Interim Futility Analysis in the Phase 3 RESULT Clinical Study of Sollpura 148

10 Appendix 149

10.1 Research Methodology 150

10.1.1 Coverage 150

10.1.2 Secondary Research 150

10.1.3 Primary Research 151

10.1.4 Market Modeling and Forecasting 152

10.1.5 Company Share Analysis 153

10.1.6 Distribution Share Analysis 154

10.1.7 Benchmarking 154

10.2 GlobalData Consulting 154

10.3 Contact Us 155

10.4 Disclaimer 155

Table

1.1 List of Tables

Table 1: Cardiac Rhythm Management Devices Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2015-2025 13

Table 2: Cardiac Rhythm Management Devices Market, North America, Revenue ($m), Historic, USD Constant, 2015-2020 15

Table 3: Cardiac Rhythm Management Devices Market, North America, Revenue ($m), Forecast, USD Constant, 2021-2025 16

Table 4: Cardiac Rhythm Management Devices Market, North America, Volume (Units), 2015-2025 18

Table 5: Cardiac Rhythm Management Devices Market, North America, Volume (Units), 2015-2020 20

Table 6: Cardiac Rhythm Management Devices Market, North America, Volume (Units), 2021-2025 21

Table 7: Cardiac Rhythm Management Devices Market, North America, Company Share by Revenue ($m), USD Constant, 2017 23

Table 8: Cardiac Rhythm Management Devices Market, Canada, Revenue ($m), USD Constant, 2015-2020 25

Table 9: Cardiac Rhythm Management Devices Market, Canada, Revenue ($m), USD Constant, 2021-2025 26

Table 10: Cardiac Resynchronisation Therapy (CRT) Market, Canada, Revenue ($m), USD Constant, 2015-2020 28

Table 11: Cardiac Resynchronisation Therapy (CRT) Market, Canada, Revenue ($m), USD Constant, 2021-2025 29

Table 12: Implantable Cardioverter Defibrillators (ICD) Market, Canada, Revenue ($m), USD Constant, 2015-2020 31

Table 13: Implantable Cardioverter Defibrillators (ICD) Market, Canada, Revenue ($m), USD Constant, 2021-2025 32

Table 14: Pacemakers Market, Canada, Revenue ($m), USD Constant, 2015-2020 34

Table 15: Pacemakers Market, Canada, Revenue ($m), USD Constant, 2021-2025 35

Table 16: Cardiac Rhythm Management Devices Market, Canada, Volume (Units), 2015-2020 37

Table 17: Cardiac Rhythm Management Devices Market, Canada, Volume (Units), 2021-2025 38

Table 18: Cardiac Resynchronisation Therapy (CRT) Market, Canada, Volume (Units), 2015-2020 40

Table 19: Cardiac Resynchronisation Therapy (CRT) Market, Canada, Volume (Units), 2021-2025 41

Table 20: Implantable Cardioverter Defibrillators (ICD) Market, Canada, Volume (Units), 2015-2020 43

Table 21: Implantable Cardioverter Defibrillators (ICD) Market, Canada, Volume (Units), 2021-2025 44

Table 22: Pacemakers Market, Canada, Volume (Units), 2015-2020 46

Table 23: Pacemakers Market, Canada, Volume (Units), 2021-2025 47

Table 24: Cardiac Rhythm Management Devices Market, Canada, Average Price ($), 2015-2020 48

Table 25: Cardiac Rhythm Management Devices Market, Canada, Average Price ($), 2021-2025 49

Table 26: Cardiac Rhythm Management Devices Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2017 50

Table 27: Cardiac Rhythm Management Devices Market, Canada, Company Share by Revenue ($m), USD Constant, 2017 52

Table 28: Cardiac Rhythm Management Devices Market, Mexico, Revenue ($m), USD Constant, 2015-2020 54

Table 29: Cardiac Rhythm Management Devices Market, Mexico, Revenue ($m), USD Constant, 2021-2025 55

Table 30: Cardiac Resynchronisation Therapy (CRT) Market, Mexico, Revenue ($m), USD Constant, 2015-2020 57

Table 31: Cardiac Resynchronisation Therapy (CRT) Market, Mexico, Revenue ($m), USD Constant, 2021-2025 57

Table 32: Implantable Cardioverter Defibrillators (ICD) Market, Mexico, Revenue ($m), USD Constant, 2015-2020 59

Table 33: Implantable Cardioverter Defibrillators (ICD) Market, Mexico, Revenue ($m), USD Constant, 2021-2025 59

Table 34: Pacemakers Market, Mexico, Revenue ($m), USD Constant, 2015-2020 61

Table 35: Pacemakers Market, Mexico, Revenue ($m), USD Constant, 2021-2025 61

Table 36: Cardiac Rhythm Management Devices Market, Mexico, Volume (Units), 2015-2020 63

Table 37: Cardiac Rhythm Management Devices Market, Mexico, Volume (Units), 2021-2025 64

Table 38: Cardiac Resynchronisation Therapy (CRT) Market, Mexico, Volume (Units), 2015-2020 66

Table 39: Cardiac Resynchronisation Therapy (CRT) Market, Mexico, Volume (Units), 2021-2025 66

Table 40: Implantable Cardioverter Defibrillators (ICD) Market, Mexico, Volume (Units), 2015-2020 68

Table 41: Implantable Cardioverter Defibrillators (ICD) Market, Mexico, Volume (Units), 2021-2025 68

Table 42: Pacemakers Market, Mexico, Volume (Units), 2015-2020 70

Table 43: Pacemakers Market, Mexico, Volume (Units), 2021-2025 70

Table 44: Cardiac Rhythm Management Devices Market, Mexico, Average Price ($), 2015-2020 71

Table 45: Cardiac Rhythm Management Devices Market, Mexico, Average Price ($), 2021-2025 72

Table 46: Cardiac Rhythm Management Devices Market, Mexico, Distribution Share by Revenue ($m), USD Constant, 2017 73

Table 47: Cardiac Rhythm Management Devices Market, Mexico, Company Share by Revenue ($m), USD Constant, 2017 75

Table 48: Cardiac Rhythm Management Devices Market, United States, Revenue ($m), USD Constant, 2015-2020 77

Table 49: Cardiac Rhythm Management Devices Market, United States, Revenue ($m), USD Constant, 2021-2025 78

Table 50: Cardiac Resynchronisation Therapy (CRT) Market, United States, Revenue ($m), USD Constant, 2015-2020 80

Table 51: Cardiac Resynchronisation Therapy (CRT) Market, United States, Revenue ($m), USD Constant, 2021-2025 80

Table 52: Implantable Cardioverter Defibrillators (ICD) Market, United States, Revenue ($m), USD Constant, 2015-2020 82

Table 53: Implantable Cardioverter Defibrillators (ICD) Market, United States, Revenue ($m), USD Constant, 2021-2025 82

Table 54: Pacemakers Market, United States, Revenue ($m), USD Constant, 2015-2020 84

Table 55: Pacemakers Market, United States, Revenue ($m), USD Constant, 2021-2025 84

Table 56: Cardiac Rhythm Management Devices Market, United States, Volume (Units), 2015-2020 86

Table 57: Cardiac Rhythm Management Devices Market, United States, Volume (Units), 2021-2025 87

Table 58: Cardiac Resynchronisation Therapy (CRT) Market, United States, Volume (Units), 2015-2020 89

Table 59: Cardiac Resynchronisation Therapy (CRT) Market, United States, Volume (Units), 2021-2025 89

Table 60: Implantable Cardioverter Defibrillators (ICD) Market, United States, Volume (Units), 2015-2020 91

Table 61: Implantable Cardioverter Defibrillators (ICD) Market, United States, Volume (Units), 2021-2025 91

Table 62: Pacemakers Market, United States, Volume (Units), 2015-2020 93

Table 63: Pacemakers Market, United States, Volume (Units), 2021-2025 93

Table 64: Cardiac Rhythm Management Devices Market, United States, Average Price ($), 2015-2020 94

Table 65: Cardiac Rhythm Management Devices Market, United States, Average Price ($), 2021-2025 95

Table 66: Cardiac Rhythm Management Devices Market, United States, Distribution Share by Revenue ($m), USD Constant, 2017 96

Table 67: Cardiac Rhythm Management Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2017 98

Table 68: Cardiac Rhythm Management Devices Market Pipeline Products 100

Table 69: Total Number of Primary Research Participants, Cardiovascular Devices Market, by Country 152

Figures

1.2 List of Figures

Figure 1: Cardiac Rhythm Management Devices Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2015-2025 12

Figure 2: Cardiac Rhythm Management Devices Market, North America, Revenue ($m), Historic, USD Constant, 2015-2025 14

Figure 3: Cardiac Rhythm Management Devices Market, North America, Volume (Units), 2015-2025 17

Figure 4: Cardiac Rhythm Management Devices Market, North America, Volume (Units), 2015-2025 19

Figure 5: Cardiac Rhythm Management Devices Market, North America, Company Share (%) 2017 22

Figure 6: Cardiac Rhythm Management Devices Market, Canada, Revenue ($m), USD Constant, 2015-2025 24

Figure 7: Cardiac Resynchronisation Therapy (CRT) Market, Canada, Revenue ($m), USD Constant, 2015-2025 27

Figure 8: Implantable Cardioverter Defibrillators (ICD) Market, Canada, Revenue ($m), USD Constant, 2015-2025 30

Figure 9: Pacemakers Market, Canada, Revenue ($m), USD Constant, 2015-2025 33

Figure 10: Cardiac Rhythm Management Devices Market, Canada, Volume (Units), 2015-2025 36

Figure 11: Cardiac Resynchronisation Therapy (CRT) Market, Canada, Volume (Units), 2015-2025 39

Figure 12: Implantable Cardioverter Defibrillators (ICD) Market, Canada, Volume (Units), 2015-2025 42

Figure 13: Pacemakers Market, Canada, Volume (Units), 2015-2025 45

Figure 14: Cardiac Rhythm Management Devices Market, Canada, Company Share (%) 2017 51

Figure 15: Cardiac Rhythm Management Devices Market, Mexico, Revenue ($m), USD Constant, 2015-2025 53

Figure 16: Cardiac Resynchronisation Therapy (CRT) Market, Mexico, Revenue ($m), USD Constant, 2015-2025 56

Figure 17: Implantable Cardioverter Defibrillators (ICD) Market, Mexico, Revenue ($m), USD Constant, 2015-2025 58

Figure 18: Pacemakers Market, Mexico, Revenue ($m), USD Constant, 2015-2025 60

Figure 19: Cardiac Rhythm Management Devices Market, Mexico, Volume (Units), 2015-2025 62

Figure 20: Cardiac Resynchronisation Therapy (CRT) Market, Mexico, Volume (Units), 2015-2025 65

Figure 21: Implantable Cardioverter Defibrillators (ICD) Market, Mexico, Volume (Units), 2015-2025 67

Figure 22: Pacemakers Market, Mexico, Volume (Units), 2015-2025 69

Figure 23: Cardiac Rhythm Management Devices Market, Mexico, Company Share (%) 2017 74

Figure 24: Cardiac Rhythm Management Devices Market, United States, Revenue ($m), USD Constant, 2015-2025 76

Figure 25: Cardiac Resynchronisation Therapy (CRT) Market, United States, Revenue ($m), USD Constant, 2015-2025 79

Figure 26: Implantable Cardioverter Defibrillators (ICD) Market, United States, Revenue ($m), USD Constant, 2015-2025 81

Figure 27: Pacemakers Market, United States, Revenue ($m), USD Constant, 2015-2025 83

Figure 28: Cardiac Rhythm Management Devices Market, United States, Volume (Units), 2015-2025 85

Figure 29: Cardiac Resynchronisation Therapy (CRT) Market, United States, Volume (Units), 2015-2025 88

Figure 30: Implantable Cardioverter Defibrillators (ICD) Market, United States, Volume (Units), 2015-2025 90

Figure 31: Pacemakers Market, United States, Volume (Units), 2015-2025 92

Figure 32: Cardiac Rhythm Management Devices Market, United States, Company Share (%) 2017 97

Frequently asked questions

North America Cardiac Rhythm Management Devices Market Outlook to 2025 standard reports
Currency USD
$5,995

Can be used by individual purchaser only

Most Popular
$11,990

Can be shared by unlimited users within one corporate location e.g. a regional office

$17,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Cardiovascular Devices reports
Medical Devices
New
PTA Peripheral DCB Catheters Pipeline by Development Stages, Segments, Region…
$4,000 | March 2024
Medical Devices
New
PCR Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Medical Devices
New
Immunochemistry Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at North America Cardiac Rhythm Management Devices Market Outlook to 2025 in real time.

  • Access a live North America Cardiac Rhythm Management Devices Market Outlook to 2025 dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more